| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/06/1993 | CA2088836A1 1,4-dihydropyridine compounds, processes for preparation thereof and pharmaceutical compositions comprising the same |
| 08/06/1993 | CA2088719A1 Antitumor compositions and methods of treatment |
| 08/05/1993 | WO1993015405A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 08/05/1993 | WO1993015207A2 Hepatitis therapeutics |
| 08/05/1993 | WO1993015203A2 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 08/05/1993 | WO1993015202A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | WO1993015083A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/05/1993 | WO1993014787A1 Taxol as a radiation sensitizer |
| 08/05/1993 | WO1993014774A1 Use of aqueous solutions containing peroxobisulphate ions for the treatment of malignant cells |
| 08/05/1993 | WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 08/05/1993 | CA2129115A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 08/05/1993 | CA2128896A1 Hepatitis therapeutics |
| 08/05/1993 | CA2128879A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | CA2128779A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/05/1993 | CA2128728A1 Use of aqueous solutions containing peroxobisulphate ions for the treatment of malignant cells |
| 08/05/1993 | CA2128700A1 Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor |
| 08/05/1993 | CA2128693A1 Taxol as a radiation sensitizer |
| 08/04/1993 | EP0553890A1 Diphenyl heteroalkyl derivatives, their preparation, as well as medicinal and cosmetic preparations prepared therefrom |
| 08/04/1993 | EP0553884A1 Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
| 08/04/1993 | EP0553786A2 Salts of glucopyranose derivative and its intermediate |
| 08/04/1993 | EP0553294A1 Methods and compositions for the treatment of cell proliferation disorders |
| 08/04/1993 | EP0553281A1 Preparation and characterization of liposomal formulations of tumor necrosis factor. |
| 08/04/1993 | EP0553156A1 Chromans and thiochromans with retinoid-like activity |
| 08/04/1993 | EP0355095B1 Pharmacological agent-lipid solution preparation |
| 08/04/1993 | EP0351435B1 Fused pyridazine compounds and their medicinal uses |
| 08/04/1993 | CN1074826A Pharmaceutical compositions |
| 08/03/1993 | US5233031 Phosphoramidate analogs of 2'-deoxyuridine |
| 08/03/1993 | CA1320957C Pyridazinone derivatives |
| 08/03/1993 | CA1320952C Antitumor alkaloids |
| 08/03/1993 | CA1320906C Interleukin-2 induced antineoplastic peptide |
| 07/31/1993 | CA2088390A1 Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them |
| 07/29/1993 | DE4201858A1 Mittel zur behandlung maligner zellen Agents for the treatment of malignant cells |
| 07/28/1993 | EP0552974A1 A 1-aryl-2-(1H-1,2-4-triazol-1-yl) ethanol derivative and antifungal compositions containing that derivative |
| 07/28/1993 | EP0552881A1 Anticancer benzaldehyde compounds |
| 07/28/1993 | EP0552880A1 Anticancer benzaldehyde compounds |
| 07/28/1993 | EP0552767A2 3'-derivatised oligonucleotide analogues with non-nucleotidic groups, their preparation and use |
| 07/28/1993 | EP0552766A2 Oligonucleotide analogues, their preparation and use |
| 07/28/1993 | EP0552624A1 Pharmaceutical compositions containing 9-cis retinoic acid, salts and esters thereof |
| 07/28/1993 | EP0552553A1 Sulfonimidamides as antineoplastic agents |
| 07/28/1993 | EP0552552A2 5-Deazafolic acid derivatives and their use as antineoplastics agents |
| 07/28/1993 | EP0552329A1 Methylen-oxindole derivatives and process for their preparation |
| 07/28/1993 | EP0552302A1 Method of inhibiting transcription utilizing nuclear receptors |
| 07/28/1993 | EP0552296A1 Mouse monoclonal antibodies |
| 07/28/1993 | EP0552257A1 A plant protein useful for treating tumors and hiv infection |
| 07/28/1993 | EP0552188A1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
| 07/28/1993 | EP0502936B1 Mitonaphide infusion solution |
| 07/28/1993 | EP0495014A4 Novel oxidized lipoproteins and methods for their preparation |
| 07/28/1993 | EP0294491B1 Antibiotic yi-hu3 and process for its preparation |
| 07/28/1993 | CN1074684A Thioether conjugates |
| 07/27/1993 | US5231100 Antineoplastic modified imidazoacridines |
| 07/27/1993 | US5231024 Hybridoma cells |
| 07/25/1993 | CA2087824A1 1-aryl-2-(1h-1,2,4-triazol-1-yl) ethanol derivative and antifungal compositions containing that derivative |
| 07/22/1993 | WO1993014406A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 07/22/1993 | WO1993014202A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 07/22/1993 | WO1993014124A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | WO1993014112A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
| 07/22/1993 | WO1993014093A1 Metal complexes of water soluble texaphyrins |
| 07/22/1993 | WO1993014077A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| 07/22/1993 | WO1993014070A2 Novel imidazole derivatives, their preparation and therapeutic applications |
| 07/22/1993 | WO1993013806A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013794A1 Novel methods and compositions for treatment of angiogenic diseases |
| 07/22/1993 | WO1993013779A2 Use of udpg as cancer therapy rescue agent |
| 07/22/1993 | WO1993013769A1 Pyropheophorbides and their use in photodynamic therapy |
| 07/22/1993 | WO1993013751A1 Formulation and use of carotenoids in treatment of cancer |
| 07/22/1993 | CA2127540A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | CA2126687A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
| 07/22/1993 | CA2124217A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | CA2106368A1 Methods and compositions for treatment of angiogenic disease |
| 07/22/1993 | CA2087656A1 New compounds |
| 07/22/1993 | CA2087651A1 Compounds |
| 07/21/1993 | EP0551849A1 Novel arylcycloalkyl derivatives their production and their use |
| 07/21/1993 | EP0551442A1 Self-assembling ion pair drugs |
| 07/21/1993 | EP0551294A1 Ribozyme inhibition of bcr-abl gene expression |
| 07/20/1993 | US5229375 Antitumor agents, antigrowth agents and DNA cleaving property |
| 07/20/1993 | US5229109 Cancer treatment; side effect reduction |
| 07/14/1993 | EP0550697A1 Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same |
| 07/14/1993 | EP0550663A1 Modified antibodies with controlled clearance time |
| 07/14/1993 | EP0550589A1 Substituted tricyclic compounds |
| 07/14/1993 | EP0550580A1 Uracil reductase inactivators |
| 07/14/1993 | EP0550566A1 Antiproliferative substituted naphthalene compounds |
| 07/14/1993 | EP0550561A1 Purification of cytokeratin fragments |
| 07/13/1993 | US5227400 Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
| 07/13/1993 | US5227393 α-fluoro-α-tetrazolyl-phenylmethyl derivatives useful as aromatase inhibitors |
| 07/13/1993 | US5227373 Lyophilized ifosfamide compositions |
| 07/13/1993 | CA1320210C 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1, 4-dithiins and treatment of leukemia and tumors therewith |
| 07/13/1993 | CA1320207C Hemiphosphate hemihydrate of 2(2-pentyl-3-guanidino) -4-(2-methyl-4-imidazolyl)thiazole |
| 07/08/1993 | WO1993013123A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids |
| 07/08/1993 | WO1993013121A1 Gapped 2' modified oligonucleotides |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993012808A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | WO1993012799A1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis |
| 07/08/1993 | WO1993012756A2 Transfection of lung via aerosolized transgene delivery |
| 07/08/1993 | WO1993012654A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | WO1993010743A3 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 07/08/1993 | CA2126757A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2126108A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/07/1993 | EP0550157A1 Antitumor compositions and methods of treatment |
| 07/07/1993 | EP0550112A1 2-Saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and pharmaceutical compositions contaning them |
| 07/07/1993 | EP0550111A1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them |